Literature DB >> 24204062

Risk-adjusted comparison of blood pressure and low-density lipoprotein (LDL) noncontrol in primary care offices.

Karl Hammermeister1, Michael Bronsert, William G Henderson, Letoynia Coombs, Patrick Hosokawa, Elias Brandt, Cathy Bryan, Robert Valuck, David West, Winston Liaw, Michael Ho, Wilson Pace.   

Abstract

OBJECTIVES: Population-level control of modifiable cardiovascular disease (CVD) risk factors is suboptimal. The objectives of this study were (1) to demonstrate the use of electronically downloaded electronic health record (EHR) data to assess guideline concordance in a large cohort of primary care patients, (2) to provide a contemporary assessment of blood pressure (BP) and low-density lipoprotein (LDL) noncontrol in primary care, and (3) to demonstrate the effect of risk adjustment of rates of noncontrol of BP and LDL for differences in patient mix on these clinic-level performance measures.
METHODS: This was an observational comparative effectiveness study that included 232,172 adult patients ≥18 years old with ≥1 visit within 2 years in 33 primary care clinics with EHRs. The main measures were rates of BP and LDL noncontrol based on current guidelines and were calculated from electronically downloaded EHR data. Rates of noncontrol were risk-adjusted using multivariable models of patient-level variables.
RESULTS: Overall, 16.0% of the 227,122 patients with known BP and 14.9% of the 136,771 patients with known LDL were uncontrolled. Clinic-level, risk-adjusted BP noncontrol ranged from 7.7% to 26.5%, whereas that for LDL ranged from 5.8% to 23.6%. Rates of noncontrol exceeded an achievable benchmark for 85% (n = 28) and 79% (n = 26) of the 33 clinics for BP and LDL, respectively. Risk adjustment significantly influences clinic rank order for rate of noncontrol.
CONCLUSIONS: We demonstrated that the use of electronic collection of data from a large cohort of patients from fee-for-service primary care clinics is feasible for the audit of and feedback on BP and LDL noncontrol. Rates of noncontrol for most clinics are substantially higher than those achievable. Risk adjustment of noncontrol rates results in a rank-order of clinics very different from that achieved with nonadjusted data.

Entities:  

Keywords:  Blood Pressure; Cholesterol; Clinical Practice Guideline; Electronic Health Records; Feedback; Health Information Management

Mesh:

Substances:

Year:  2013        PMID: 24204062      PMCID: PMC4544740          DOI: 10.3122/jabfm.2013.06.130017

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  27 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study.

Authors:  Atsushi Hozawa; Aaron R Folsom; A Richey Sharrett; Lloyd E Chambless
Journal:  Arch Intern Med       Date:  2007-03-26

3.  Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes.

Authors:  Anne M Libby; Wilson Pace; Cathy Bryan; Heather Orton Anderson; Samuel L Ellis; Richard Read Allen; Elias Brandt; Amy G Huebschmann; David West; Robert J Valuck
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

4.  An electronic practice-based network for observational comparative effectiveness research.

Authors:  Wilson D Pace; Maribel Cifuentes; Robert J Valuck; Elizabeth W Staton; Elias C Brandt; David R West
Journal:  Ann Intern Med       Date:  2009-07-28       Impact factor: 25.391

5.  Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial.

Authors:  C I Kiefe; J J Allison; O D Williams; S D Person; M T Weaver; N W Weissman
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

6.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

7.  Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Justin G Trogdon; Olga A Khavjou; Javed Butler; Kathleen Dracup; Michael D Ezekowitz; Eric Andrew Finkelstein; Yuling Hong; S Claiborne Johnston; Amit Khera; Donald M Lloyd-Jones; Sue A Nelson; Graham Nichol; Diane Orenstein; Peter W F Wilson; Y Joseph Woo
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

8.  Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-04       Impact factor: 17.586

9.  Building sustainable multi-functional prospective electronic clinical data systems.

Authors:  Gurvaneet S Randhawa; Jean R Slutsky
Journal:  Med Care       Date:  2012-07       Impact factor: 2.983

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more
  7 in total

Review 1.  Measuring Comprehensiveness of Primary Care: Challenges and Opportunities.

Authors:  Ann S O'Malley; Eugene C Rich
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

2.  New approaches to measuring the comprehensiveness of primary care physicians.

Authors:  Ann S O'Malley; Eugene C Rich; Lisa Shang; Tyler Rose; Arkadipta Ghosh; Dmitriy Poznyak; Deborah Peikes
Journal:  Health Serv Res       Date:  2019-01-06       Impact factor: 3.402

3.  The Affordable Care Act: Effects of Insurance on Diabetes Biomarkers.

Authors:  Miguel Marino; Heather Angier; Rachel Springer; Steele Valenzuela; Megan Hoopes; Jean O'Malley; Andrew Suchocki; John Heintzman; Jennifer DeVoe; Nathalie Huguet
Journal:  Diabetes Care       Date:  2020-07-01       Impact factor: 19.112

4.  Active Use of Electronic Health Records (EHRs) and Personal Health Records (PHRs) for Epidemiologic Research: Sample Representativeness and Nonresponse Bias in a Study of Women During Pregnancy.

Authors:  Julie K Bower; Claire E Bollinger; Randi E Foraker; Darryl B Hood; Abigail B Shoben; Albert M Lai
Journal:  EGEMS (Wash DC)       Date:  2017-02-23

Review 5.  The use of Electronic Health Records to Support Population Health: A Systematic Review of the Literature.

Authors:  Clemens Scott Kruse; Anna Stein; Heather Thomas; Harmander Kaur
Journal:  J Med Syst       Date:  2018-09-29       Impact factor: 4.460

6.  Disparities in Biomarkers for Patients With Diabetes After the Affordable Care Act.

Authors:  Miguel Marino; Heather Angier; Katie Fankhauser; Steele Valenzuela; Megan Hoopes; John Heintzman; Jennifer DeVoe; Laura Moreno; Nathalie Huguet
Journal:  Med Care       Date:  2020-06       Impact factor: 3.178

7.  A cluster randomized trial on the effect of a multifaceted intervention improved the technical quality of diabetes care by primary care physicians: The Japan Diabetes Outcome Intervention Trial-2 (J-DOIT2).

Authors:  Y Hayashino; H Suzuki; K Yamazaki; A Goto; K Izumi; M Noda
Journal:  Diabet Med       Date:  2015-10-09       Impact factor: 4.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.